Clinical trials
Enrolling by invitation Observational Metabolic Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Dong Peng | 1 |
| Havva Betül Bacak | 1 |
| Linkoeping University | 1 |
| National Taiwan University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Syndrome | 5 |
| Diabetes Mellitus, Type 2 | 2 |
| Obesity | 2 |
| Overweight | 2 |
| Cardiovascular Diseases | 1 |
| Fibrosis | 1 |
| Hypertension | 1 |
| Insulin Resistance | 1 |
| Non-alcoholic Fatty Liver Disease | 1 |
| Polycystic Ovary Syndrome | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.